[HTML][HTML] Design of therapeutic biomaterials to control inflammation

Z Tu, Y Zhong, H Hu, D Shao, R Haag… - Nature Reviews …, 2022 - nature.com
Inflammation plays an important role in the response to danger signals arising from damage
to our body and in restoring homeostasis. Dysregulated inflammatory responses occur in …

Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic

S Noreen, I Maqbool, A Madni - European journal of pharmacology, 2021 - Elsevier
The current outbreak of novel COVID-19 challenges the development of an efficient
treatment plan as soon as possible. Several promising treatment options stand out as …

[HTML][HTML] Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy

P Zhao, X Xia, X Xu, KKC Leung, A Rai, Y Deng… - Nature …, 2021 - nature.com
A key challenge for the effective treatment of gastrointestinal diseases including
inflammatory bowel disease is to develop an orally administered drug delivery system …

A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes

X Wang, KG Maxwell, K Wang, DT Bowers… - Science translational …, 2021 - science.org
Transplantation of stem cell–derived β (SC-β) cells represents a promising therapy for type 1
diabetes (T1D). However, the delivery, maintenance, and retrieval of these cells remain a …

Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases

W He, N Kapate, CW Shields IV, S Mitragotri - Advanced drug delivery …, 2020 - Elsevier
Macrophages play a key role in defending against foreign pathogens, healing wounds, and
regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which …

Macrophage-based therapeutic strategies in regenerative medicine

KL Spiller, TJ Koh - Advanced drug delivery reviews, 2017 - Elsevier
Mounting evidence suggests that therapeutic cell and drug delivery strategies designed to
actively harness the regenerative potential of the inflammatory response have great …

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain

J Nong, PM Glassman, JW Myerson… - ACS …, 2023 - ACS Publications
Ex vivo-loaded white blood cells (WBC) can transfer cargo to pathological foci in the central
nervous system (CNS). Here we tested affinity ligand driven in vivo loading of WBC in order …

[HTML][HTML] Type 1 diabetes and engineering enhanced islet transplantation

A Jeyagaran, C Lu, A Zbinden, AL Birkenfeld… - Advanced drug delivery …, 2022 - Elsevier
The development of new therapeutic approaches to treat type 1 diabetes mellitus (T1D)
relies on the precise understanding and deciphering of insulin-secreting β-cell biology, as …

Extracellular matrix bioscaffolds as immunomodulatory biomaterials

JL Dziki, L Huleihel, ME Scarritt… - Tissue Engineering Part …, 2017 - liebertpub.com
Suppression of the recipient immune response is a common component of tissue and organ
transplantation strategies and has also been used as a method of mitigating the …

Engineering immunomodulatory biomaterials for type 1 diabetes

CL Stabler, Y Li, JM Stewart… - Nature Reviews Materials, 2019 - nature.com
A cure for type 1 diabetes (T1D) would help millions of people worldwide but remains
elusive to date. Tolerogenic vaccines and β-cell replacement therapy are complementary …